Post-dipyridamole myocardial perfusion SPECT is a nuclear medicine test used to evaluate heart function and detect the presence of heart disease such as coronary artery disease.
During the test, dipyridamole, a drug that replaces exercise in patients who are unable to exercise, is administered. After dipyridamole is administered, a small amount of radioactive material is injected into the body, which attaches to the heart cells and emits radiation.
A series of SPECT (single photon emission computed tomography) images of the heart are taken while the patient is lying on a special table. These images allow doctors to visualize the distribution of radioactive material in the heart and assess blood flow in the coronary arteries.
The examination is performed in two stages: myocardial perfusion at rest, and
myocardial perfusion after dipyridamole. Comparing the images from both stages helps identify areas of the heart with decreased blood flow, which may indicate a blockage in the coronary arteries.
APPOINTMENT
If you have an appointment, you must have a doctor's referral.
SCHEDULE
Check the study schedule from Monday to Friday from 8 a.m. to 7:30 p.m.
PREVIOUS STUDIES
Previous studies must be brought along.
WHERE TO HAVE THE TEST
Admission must be completed at the reception desk, and then the study is performed in Nuclear Medicine.
